Advancements in Anemia Management during Pregnancy: The Role of Recombinant Erythropoietin and Dietary Interventions

  • Unique Paper ID: 176087
  • Volume: 11
  • Issue: 11
  • PageNo: 4916-4921
  • Abstract:
  • Anemia during pregnancy, predominantly caused by iron deficiency, remains a major global health concern, particularly in low- and middle-income countries. This review compiles evidence from 25 significant studies assessing various biotechnological and dietary approaches to manage and mitigate iron-deficiency anemia (IDA) in pregnant women. Interventions such as recombinant erythropoietin, iron-fortified foods, micronutrient-rich beverages, and iron-folic acid supplementation have demonstrated variable success in improving maternal hemoglobin and iron status. While daily iron supplementation proves more effective than intermittent strategies, concerns about side effects and compliance persist. Nutritional counseling and fortified diets, especially when combined with targeted supplementation strategies, significantly reduce anemia prevalence and improve maternal and neonatal outcomes. Moreover, studies highlight the importance of micronutrients like zinc, vitamin C, and vitamin D in supporting hematopoiesis and enhancing iron absorption. Innovations in delivery methods, such as prolonged-release supplements and direct observation for improved adherence, also show promise. However, gaps in early pregnancy supplementation, disparities in resource access, and variations in compliance continue to hinder large-scale effectiveness. This review underscores the need for integrative, personalized, and evidence-based anemia management strategies that combine biotechnology.

Related Articles